Evidence map›Paper›PMID 39882872›Full record

ArticlemSphere2025

Dysregulation of lung epithelial cell homeostasis and immunity contributes to Middle East respiratory syndrome coronavirus disease severity.

Amy C Sims, Alexandra Schäfer, Kenichi Okuda, Sarah R Leist, Jacob F Kocher, Adam S Cockrell, Padraig E Hawkins, Minako Furusho, Kara L Jensen, Jennifer E Kyle and 12 more

Abstract read
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Amy C SimsDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Alexandra SchäferDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Kenichi OkudaMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Sarah R LeistDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Jacob F KocherDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Adam S CockrellDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Padraig E HawkinsMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Minako FurushoMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Kara L JensenDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Jennifer E KyleBiological Sciences Division, Pacific Northwest National Laboratories, Richland, Washington, USA.
Kristin E Burnum-JohnsonBiological Sciences Division, Pacific Northwest National Laboratories, Richland, Washington, USA.ORCID 0000-0002-2722-4149
Kelly G StrattonBiological Sciences Division, Pacific Northwest National Laboratories, Richland, Washington, USA.
Natalie C LamarAI & Data Analytics Division, Pacific Northwest National Laboratories, Richland, Washington, USA.
Carrie D NiccoraBiological Sciences Division, Pacific Northwest National Laboratories, Richland, Washington, USA.
Karl K WeitzBiological Sciences Division, Pacific Northwest National Laboratories, Richland, Washington, USA.
Richard D SmithBiological Sciences Division, Pacific Northwest National Laboratories, Richland, Washington, USA.
Thomas O MetzBiological Sciences Division, Pacific Northwest National Laboratories, Richland, Washington, USA.ORCID 0000-0001-6049-3968
Katrina M WatersBiological Sciences Division, Pacific Northwest National Laboratories, Richland, Washington, USA.
Richard C BoucherMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Stephanie A MontgomeryDepartment of Pathology & Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Ralph S BaricDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0001-6827-8701
Timothy P SheahanDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0001-9181-2183

Funding

Research Project 1: Coronavirus antiviral lead development and combination testingU19AI171292 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARIC, RALPH S, WILLSON, TIMOTHY M · 2022 to 2022
$65.5M
Translational CoreU19AI109761 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIPKIN, W. IAN · 2014 to 2018
$32.6M
Systems Biology Identifies Restriction Factors for West Nile VirusU19AI106772 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KAWAOKA, YOSHIHIRO · 2013 to 2017
$26.1M
Mucociliary innate defense mechanism in the human distal airwayR01HL163602 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kenichi Okuda · 2023 to 2026
$2.4M
NHLBI NIH HHS R01 HL163602NIAID NIH HHS U19 AI106772NIAID NIH HHS U19 AI109761NIAID NIH HHS U19 AI171292
6 · The paper itself

Abstract

Coronaviruses (CoV) emerge suddenly from animal reservoirs to cause novel diseases in new hosts. Discovered in 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) is endemic in camels in the Middle East and is continually causing local outbreaks and epidemics. While all three newly emerging human CoVs from the past 20 years (SARS-CoV, SARS-CoV-2, and MERS-CoV) cause respiratory disease, each CoV has unique host interactions that drive differential pathogeneses. To better understand the virus and host interactions driving lethal MERS-CoV infection, we performed a longitudinal multi-omics analysis of sublethal and lethal MERS-CoV infection in mice. Significant differences were observed in body weight loss, virus titers, and acute lung injury among lethal and sub-lethal virus doses. Virus-induced apoptosis of type I and II alveolar epithelial cells suggests that loss or dysregulation of these key cell populations was a major driver of severe disease. Omics analysis suggested differential pathogenesis was multi-factorial with clear differences among innate and adaptive immune pathways as well as those that regulate lung epithelial homeostasis. Infection of mice lacking functional T and B cells showed that adaptive immunity was important in controlling viral replication but also increased pathogenesis. In summary, we provide a high-resolution host response atlas for MERS-CoV infection and disease severity. Multi-omics studies of viral pathogenesis offer a unique opportunity to not only better understand the molecular mechanisms of disease but also to identify genes and pathways that can be exploited for therapeutic intervention all of which is important for our future pandemic preparedness.IMPORTANCEEmerging coronaviruses like SARS-CoV, SARS-CoV-2, and MERS-CoV cause a range of disease outcomes in humans from an asymptomatic, moderate, and severe respiratory disease that can progress to death but the factors causing these disparate outcomes remain unclear. Understanding host responses to mild and life-threatening infections provides insight into virus-host networks within and across organ systems that contribute to disease outcomes. We used multi-omics approaches to comprehensively define the host response to moderate and severe MERS-CoV infection. Severe respiratory disease was associated with dysregulation of the immune response. Key lung epithelial cell populations that are essential for lung function get infected and die. Mice lacking key immune cell populations experienced greater virus replication but decreased disease severity implicating the immune system in both protective and pathogenic roles in response to MERS-CoV. These data could be utilized to design new therapeutic strategies targeting specific pathways that contribute to severe disease.

Indexed as

Coronavirus InfectionsEpithelial CellsLungMiddle East Respiratory Syndrome CoronavirusAnimalsDisease Models, AnimalFemaleHomeostasisHost-Pathogen InteractionsHumansImmunity, InnateMiceSeverity of Illness Indexcoronavirusgenomicslung infectionMERS-CoVproteomicsSARS-CoV-2viral pathogenesis

Identifiers

PMID39882872
PMCPMC11853001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.